Full-Time
Posted on 8/14/2024
Provides components for diagnostics and medical devices
No salary listed
Senior, Expert
Remote in USA
Surmodics specializes in providing essential components for in vitro diagnostic (IVD) products and advanced coatings for medical devices. Their IVD offerings include a variety of products such as protein stabilizers, diluents, blockers, substrates, and antibodies, which are vital for creating sensitive immunoassays that detect substances in biological samples. Surmodics also develops advanced coatings for medical devices, including lubricious and hemocompatible coatings, and is known for creating the first drug delivery coating for drug-eluting stents. The company differentiates itself through close collaboration with clients, allowing for rapid product development and commercialization. Surmodics aims to support healthcare and biotechnology advancements by helping clients bring their products to market efficiently.
Company Size
201-500
Company Stage
IPO
Headquarters
Eden Prairie, Minnesota
Founded
1979
Help us improve and share your feedback! Did you find this helpful?
Performance Bonus
401(k) Company Match
401(k) Retirement Plan
Company Equity
Stock Options
Surmodics MD, LLC has introduced a groundbreaking solution for pulmonary embolism treatment with its newly patented technology.
The FTC, joined by Illinois and Minnesota, has expanded its lawsuit against GTCR over its proposed $1.75 billion acquisition of Surmodics. The complaint argues that the merger would create a dominant player in the market for outsourced hydrophilic coatings, crucial for medical devices, by eliminating competition between Surmodics and Biocoat, Inc., in which GTCR holds a majority stake. This could lead to higher prices, reduced innovation, and lower quality in medical tools.
Surmodics launches Pounce XL thrombectomy system.
Principal Financial Group Inc. makes new investment in Surmodics, Inc. (NASDAQ:SRDX).
Algert Global LLC makes new $577,000 investment in Surmodics, Inc. (NASDAQ:SRDX).